Results 71 to 80 of about 4,608 (197)

Botulinum toxin: a new differential diagnosis for a lytic bone lesion

Journal of Medical Case Reports
Background Botulinum toxin, produced by the Gram-positive anaerobe Clostridium botulinum, is composed of seven antigenic subtypes (A, B, C, D, E, F, and G). Currently, only Botulinum toxin type A, commonly referred to as “Botox,” is approved for clinical
Yael Lefkovits, Lara Lipton
doaj   +1 more source

Combined Use of Botulinum Toxin A and Profhilo for Upper Face Rejuvenation: A Randomized Clinical Trial

Health Science Reports, Volume 9, Issue 5, May 2026.
ABSTRACT Background Hyaluronic acid (HA) and Botulinum toxin A (BTX‐A) treatments are highly regarded for their effectiveness in facial rejuvenation. Aim To investigate whether adding Profhilo enhances the effects of BTX‐A for frontal skin rejuvenation.
Zahra Saffarian, Amirhossein Rahimnia, Ala Ehsani, Kamran Balighi, Amirhoushang Ehsani, Zahra Razavi, Mina Koohian Mohammadabadi, Faezeh khorasanizadeh, Ghazal Ghaffarzadeh, Parvaneh Hatami   +9 more
wiley   +1 more source

Botulinum Neurotoxin type A is effective to treat peripheral myoclonus post-amputation [PDF]

, 2019
Peripheral myoclonus is a rare post-amputation complication characterized by sudden, brief and sometimes repetitive muscle contractions. BoNT-A prevents the release of the neurotransmitter acetylcholine at the axon ending of the neuromuscular junction ...
Boudier-Réverêt, Mathieu, Sirois, Geneviève, Rodrigue, Xavier, Briand, Marie-Michèle   +3 more
core  

Over 25 Years of Pediatric Botulinum Toxin Treatments: What Have We Learned from Injection Techniques, Doses, Dilutions, and Recovery of Repeated Injections?

Toxins, 2020
Botulinum toxin type A (BTXA) has been used for over 25 years in the management of pediatric lower and upper limb hypertonia, with the first reports in 1993.
Heli Sätilä
doaj   +1 more source

Observational Evaluation of Muscle Echointensity and EMG Insertional Activity in Poststroke Spasticity

Muscle &Nerve, Volume 73, Issue 5, Page 858-866, May 2026.
ABSTRACT Introduction/Aims When spasticity occurs after a stroke, peripheral changes in spastic muscle architecture may develop. The primary objective was to determine if an association exists between spastic muscle echointensity (EI) measured by the Modified Heckmatt Scale (MHS) and changes in insertional activity detected by electromyography (EMG ...
Rajiv Reebye, Ève Boissonnault, April Jeon, Mirko Filippetti, Gina McKernan, Oluwasanmi O. Adenaiye, Alessandro Picelli, Michael C. Munin   +7 more
wiley   +1 more source

Capsaicin protects neuromuscular junctions from the inhibitory effects of botulinum neurotoxin A

, 2008
Within 24 hrs after injecting botulinum neurotoxin A (BoNT/A) into the hindlimb, mice lost the toe spread reflex and developed progressive muscle weakness. At the same time, the compound muscle action potential amplitude decreased. Injection of capsaicin
Carmen Garcia, Joseph McArdle, Kormakur Hognason, Joseph Potian, Baskaran Thyagarajan, Natalia Krivitskaya   +5 more
core  

A morphological evaluation of botulinum neurotoxin A injections into the detrusor muscle using magnetic resonance imaging [PDF]

, 2009
OBJECTIVES: Although botulinum neurotoxin type A (BoNT/A) intradetrusor injections are a recommended therapy for neurogenic detrusor overactivity (NDO), refractory to antimuscarinic drugs, a standardisation of injection technique is missing. Furthermore,
Boy, S, Schurch, B, von Hessling, A, Hodler, J, Mehnert, U, Schmid, M, Reitz, A   +6 more
core   +1 more source

Guideline of guidelines: Peyronie's disease

BJU International, Volume 137, Issue 5, Page 770-782, May 2026.
Objective To compare major Peyronie's disease (PD) guidelines, highlight key similarities and differences among panel recommendations, and identify areas requiring further research. Methods An extensive review was conducted to analyse and compare diagnostic and treatment recommendations from publicly available guidelines published by the American ...
Francesco Chierigo, Giuseppe Fallara, Marco Tozzi, Andrea Salonia, Matteo Ferro, Hussain M Alnajjar, Asif Muneer, Karl H. Pang   +7 more
wiley   +1 more source

Nodule Formation Associated With Botulinum Neurotoxin Type A Injections: Potential Triggers in 23 Patients

Plastic and Reconstructive Surgery - Global Open
Summary: The formation of nodules at injection sites following botulinum neurotoxin type A (BoNTA) treatment has recently been reported. This complication can cause significant distress for patients, primarily due to the uncertainty surrounding its etiology and progression, as well as the lack of established management ...
Hassan, Laila, Kroumpouzos, George
openaire   +2 more sources

Internal Jugular Vein Entrapment: An Underrecognized Cause of Facial Pain

European Journal of Neurology, Volume 33, Issue 5, May 2026.
ABSTRACT Background The cause of facial pain often remains unknown after ruling out dental disorders and arterial compression of the trigeminal nerve. New pathologic models and treatment options are needed. Method Review of 30 patients with unexplained facial pain who were diagnosed with internal jugular vein (IJV) entrapment.
K. Chan, M. Gharib, J. Karam, S. Won, Y. H. Cha   +4 more
wiley   +1 more source